Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT07926828
RecruitingNCT07926828ClinicalTrials.gov record

Silver Diamine Fluoride for Caries in Primary Teeth in Routine Clinical Practice

Dental Caries

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Observational
Phase
Not applicable / not listed
Age range
Not specified - 14 years
Sex eligible
All sexes
Healthy volunteers
Not accepted
Participants
101 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The goal of this observational study is to learn how well and how safely silver diamine fluoride (SDF) stops tooth decay (caries) in baby teeth when it is used in routine dental care. It will include children aged 14 years or younger with caries in their primary (baby) teeth who are treated with SDF at a public primary care dental clinic. The main questions it aims to answer are:

  • What proportion of caries lesions treated with SDF do not progress after 12 months?
  • How often do side effects occur, such as black staining of the tooth, sensitivity, abscesses, gum or skin irritation, or allergy?
  • How satisfied are parents with the treatment? Participants will receive SDF as part of their usual dental care and will attend check-up visits 1, 6, and 12 months after treatment, where the dentist will examine the treated teeth, assess oral hygiene, and ask about diet and any side effects. Parents will answer a short satisfaction questionnaire.
Read the full description

Dental caries is one of the most common chronic diseases in childhood and remains a public health problem, especially in primary teeth and in children from lower socioeconomic backgrounds attended in the public health system. Topical 38% silver diamine fluoride (SDF) is a minimally invasive treatment that arrests caries progression, with arrest rates above 70% in controlled trials. However, there is little evidence on its effectiveness and safety in routine clinical practice, particularly with current formulations that use water instead of ammonia as the vehicle and include potassium iodide to reduce staining.

This is a single-cohort prospective study conducted at the Dentistry Service of the Baix a Mar Integrated Primary Care Center (Consorci Sanitari de l'Alt Penedès i Garraf). Children with caries in primary teeth who have an indication for SDF according to the Catalan Health Department guideline "Implementation of silver diamine fluoride treatment in primary and community care dental clinics: rationale and protocol for use" will be invited to participate. SDF 38% (Riva Star) will be applied according to that guideline. Participants will be assessed at baseline and at 1, 6, and 12 months. At each follow-up, the investigator will rate caries progression (yes/no) based on visual appearance (dark, shiny, smooth surface), tactile assessment with a dental probe (hard, smooth, not sticky), absence of symptoms, stability over time, and radiographs if needed.

The primary analysis will estimate the proportion of treated lesions without progression at 12 months with its 95% confidence interval. Logistic regression will be used to explore factors associated with progression, and subgroup analyses by sex and age are planned. A sample of 101 participants allows the proportion of arrested lesions (expected around 70%) to be estimated with a precision of ±10 percentage points and 95% confidence, assuming a 20% loss to follow-up.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Boys and girls aged 14 years or younger
  • Caries in primary teeth with an indication for SDF treatment according to section 4 of the Catalan Health Department guideline "Implementation of silver diamine fluoride treatment in primary and community care dental clinics: rationale and protocol for use"
  • Signed informed consent from the parent or legal representative
  • For participants aged 12 years or older, signed informed assent adapted to their level of understanding, in addition to the consent of their legal representatives

Exclusion Criteria:

  • Spontaneous or provoked pain associated with the caries lesion
  • Deep caries lesion close to the dental pulp, according to the investigator's judgment
  • Objection by the parents or the child to the black staining caused by SDF
  • Irreversible pulpitis or pulp necrosis
  • Active oral ulcers or gingivostomatitis
  • History of allergy to silver, ammonia, or iodine
  • Participation in another study involving an experimental intervention during the period of this study and/or with a visit schedule incompatible with this study

Study population

Children aged 14 years or younger attended at the Dentistry Service of the Baix a Mar Integrated Primary Care Center who have caries in primary teeth with an indication for SDF treatment. All consecutive eligible children whose legal representatives agree to participate will be included.

Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not reported
Masking
Not reported
Children treated with silver diamine fluoride (SDF)

Children aged 14 years or younger with caries in primary teeth and an indication for SDF according to the Catalan Health Department guideline

Drug: Silver diamine fluoride 38%

Silver diamine fluoride 38% DRUG

Topical application of 38% silver diamine fluoride to caries lesions in primary teeth, following section 4.3 ("Guidelines for the use of SDF in primary and community care") of the Catalan Health Department guideline, as part of routine clinical practice.

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Proportion of treated caries lesions without progression

Time frame: 12 months after SDF application

Number of caries lesions without progression divided by the total number of caries lesions treated with SDF. Progression (yes/no) is rated by the investigator based on visual appearance, tactile assessment with a dental probe, absence of symptoms, stability over time, and radiographs if needed.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Baix a Mar Integrated Primary Care CenterVilanova i la Geltrú, Barcelona, SpainRecruiting
Nerea CáceresPRINCIPAL_INVESTIGATOR
Paula BatistaPRINCIPAL_INVESTIGATOR
View location on map ↗

Study team and timeline

Lead sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Study start
Sep 17, 2026 Actual
Primary completion
Dec 31, 2028 Estimated
Study completion
Dec 31, 2028 Estimated
First posted
Nov 9, 2026 Actual
Last updated
Nov 9, 2026 Actual

Official study contacts

Official study title

Efficacy and Safety of Silver Diamine Fluoride in Clinical Practice for the Treatment of Caries in Children With Primary Dentition

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 9, 2026